Malignant Peripheral Nerve Sheath Tumors are not a Feature of Neurofibromatosis Type 2 in the Unirradiated Patient

被引:23
|
作者
King, Andrew T. [1 ]
Rutherford, Scott A. [1 ]
Hammerbeck-Ward, Charlotte [1 ]
Lloyd, Simon K. [2 ]
Freeman, Simon R. [2 ]
Pathmanaban, Omar N. [1 ]
Kellett, Mark [3 ]
Obholzer, Rupert [4 ]
Afridi, Shazia [5 ]
Axon, Patrick [6 ]
Halliday, Dorothy [7 ]
Parry, Allyson [8 ]
Thomas, Owen M. [9 ]
Laitt, Roger D. [9 ]
McCabe, Martin G. [10 ]
Stivaros, Stavros [11 ]
Erridge, Sara [12 ]
Evans, D. Gareth [13 ]
机构
[1] Salford Royal NHS Fdn Trust, Manchester Acad, Hlth Sci Ctr, Dept Neurosurg, Manchester M6 8HD, Lancs, England
[2] Salford Royal NHS Fdn Trust, Manchester Acad, Hlth Sci Ctr, Dept Otolaryngol, Manchester, Lancs, England
[3] Salford Royal NHS Fdn Trust, Manchester Acad, Hlth Sci Ctr, Dept Neurol, Manchester, Lancs, England
[4] Guys & St Thomas Hosp, Dept Otolaryngol, London, England
[5] Guys & St Thomas Hosp, Dept Neurol, London, England
[6] Cambridge Univ Hosp NHS Fdn Trust, Dept Otolaryngol, Cambridge, England
[7] Oxford Univ Hosp NHS Trust, Dept Clin Genet, Oxford, England
[8] Oxford Univ Hosp NHS Trust, Dept Neurol, Oxford, England
[9] Salford Royal NHS Fdn Trust, Hlth Sci Ctr, Manchester Acad, Dept Neuroradiol, Manchester, Lancs, England
[10] Salford Royal NHS Fdn Trust, Hlth Sci Ctr, Manchester Acad, Ctr Paediat,Teenage & Young Adult Canc,Inst Canc, Manchester, Lancs, England
[11] Cent Manchester NHS Fdn Trust, Hlth Sci Ctr, Manchester Acad, Dept Neuroradiol, Manchester, Lancs, England
[12] Western Gen Hosp, Edinburgh Canc Ctr, Inst Canc Sci, Edinburgh, Midlothian, Scotland
[13] Cent Manchester NHS Fdn Trust, Hlth Sci Ctr, Manchester Acad, Manchester Ctr Genom Med, Manchester, Lancs, England
关键词
Neurofibromatosis type 2; Manchester criteria; Malignant peripheral nerve sheath tumors (MPNST); CEREBELLOPONTINE ANGLE LESIONS; VESTIBULAR-SCHWANNOMA; MELANOMA;
D O I
10.1093/neuros/nyx368
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: The published literature suggests that malignant peripheral nerve sheath tumors (MPNST) occur at increased frequency in neurofibromatosis type 2 (NF2). A recent review based on incidence data in North America showed that 1 per 1000 cerebellopontine angle nerve sheath tumors were malignant. OBJECTIVE: To determine whether MPNST occurred spontaneously in NF2 by reviewing our NF2 database. METHODS: The prospective database consists of 1253 patients with NF2. One thousand and nine are known to be alive at last follow-up. The presence and laterality/pathology of vestibular schwannoma at diagnosis and last follow-up was sought. RESULTS: There were no cases of spontaneous MPNST with 2114 proven (n = 1150) and presumed benign (n = 964) vestibular schwannomas found. Two patients had developed MPNST (1 presumed) after having previously undergone stereotactic radiosurgery for a vestibular schwannoma. CONCLUSION: In this series, and from the literature, malignant transformation of a vestibular schwannoma was not a feature of NF2 in the unirradiated patient. NF2 patients should not be told that they have an increased risk of malignant change in a vestibular schwannoma unless they undergo radiation treatment. However, very much larger datasets are required before it can be determined whether there is any association between NF2 and MPNST in the unirradiated patient.
引用
收藏
页码:38 / 42
页数:5
相关论文
共 50 条
  • [31] Cochlear Implantation in a Patient with Neurofibromatosis Type 2 and an Intracochlear Schwannoma: A Case Report and Literature Review
    Zhang, Dejun
    Fu, Zeming
    Han, Shuang
    Guo, Fang
    Tang, Na
    Zhao, Ying
    Guan, Guofang
    ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY, 2022, : 425 - 428
  • [32] Bevacizumab treatment for vestibular schwannoma in a patient with neurofibromatosis type 2: hearing improvement and tumor shrinkage
    Sponghini, Andrea P.
    Platini, Francesca
    Rondonotti, David
    Soffietti, Riccardo
    TUMORI, 2015, 101 (06) : E167 - E170
  • [33] Bevacizumab for Hearing Preservation in Neurofibromatosis Type 2: Emphasis on Patient-Reported Outcomes and Toxicities
    Sverak, Pavlina
    Adams, Meredith E.
    Haines, Stephen J.
    Levine, Samuel C.
    Nascene, David
    Sommer, Katherine
    Dusenbery, Kathryn
    Huang, Tina C.
    Moertel, Christopher
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2019, 160 (03) : 526 - 532
  • [34] Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2
    Huang, Victoria
    Bergner, Amanda L.
    Halpin, Chris
    Merker, Vanessa L.
    Sheridan, Monica R.
    Widemann, Brigitte C.
    Blakeley, Jaishri O.
    Plotkin, Scott R.
    OTOLOGY & NEUROTOLOGY, 2018, 39 (05) : 632 - 638
  • [35] Case Report: Contralateral Progression of a Vestibular Schwannoma After Resection in a Patient with Neurofibromatosis Type 2
    Rampalli, Ihika
    English, Collin William
    Lazaro, Tyler
    Lovin, Benjamin Daniel
    Lee, Sungho
    Huang, Andrew Tsao
    Jalali, Ali
    Gallagher, Kathleen Kelly
    Mandel, Jacob J.
    Sweeney, Alex Daniel
    Patel, Akash J.
    NEUROSURGERY PRACTICE, 2024, 5 (01):
  • [36] Cochlear implantation in the neurofibromatosis type 2 patient: Long-term follow-up
    Neff, Brian A.
    Wiet, R. Mark
    Lasak, John M.
    Cohen, Noel L.
    Pillsbury, Harold C.
    Ramsden, Richard T.
    Welling, D. Bradley
    LARYNGOSCOPE, 2007, 117 (06) : 1069 - 1072
  • [37] Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors Clinical article
    Dirks, Michael S.
    Butman, John A.
    Kim, H. Jeffrey
    Wu, Tianxia
    Morgan, Keaton
    Tran, Anne P.
    Lonser, Russell R.
    Asthagiri, Ashok R.
    JOURNAL OF NEUROSURGERY, 2012, 117 (01) : 109 - 117
  • [38] Prevalence and detection of actionable BRAF V600 and NRAS Q61 mutations in malignant peripheral nerve sheath tumor by droplet digital PCR
    Kao, Erica Y.
    Wakeman, Kristina M.
    Wu, Yu
    Gross, John M.
    Chen, Eleanor Y.
    Ricciotti, Robert W.
    Liu, Yajuan J.
    Mantilla, Jose G.
    HUMAN PATHOLOGY, 2022, 129 : 90 - 97
  • [39] Bilateral intracochlear schwannomas in a patient with no genetic or clinical features of neurofibromatosis type 2. German version
    Withers, S.
    Plontke, S. K.
    Boeddinghaus, R.
    Kuthubutheen, J.
    Atlas, M.
    HNO, 2020, 68 (07) : 534 - 538
  • [40] Stereotactic Radiosurgery for Vestibular Schwannoma in Neurofibromatosis Type 2: An International Multicenter Case Series of Response and Malignant Transformation Risk
    Bin-Alamer, Othman
    Faramand, Andrew
    Alarifi, Norah A.
    Wei, Zhishuo
    Mallela, Arka N.
    Lu, Victor M.
    Nabeel, Ahmed M.
    Reda, Wael A.
    Tawadros, Sameh R.
    Abdelkarim, Khaled
    El-Shehaby, Amr M. N.
    Emad, Reem M.
    Peker, Selcuk
    Samanci, Yavuz
    Lee, Cheng-chia
    Yang, Huai-che
    Delabar, Violaine
    Mathieu, David
    Tripathi, Manjul
    Kearns, Kathryn Nicole
    Bunevicius, Adomas
    Sheehan, Jason P.
    Chytka, Tomas
    Liscak, Roman
    Moreno, Nuria Martinez
    Alvarez, Roberto Martinez
    Grills, Inga S.
    Parzen, Jacob S.
    Cifarelli, Christopher P.
    Rehman, Azeem A.
    Speckter, Herwin
    Niranjan, Ajay
    Lunsford, L. Dade
    Abou-Al-Shaar, Hussam
    NEUROSURGERY, 2023, 92 (05) : 934 - 944